| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.02 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.03 |